REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 39 filers reported holding REDHILL BIOPHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $59,000 | -9.2% | 8,103 | +1.5% | 0.00% | – |
| Q4 2020 | $65,000 | -61.3% | 7,984 | -51.3% | 0.00% | – |
| Q3 2020 | $168,000 | +55.6% | 16,378 | +2.1% | 0.00% | – |
| Q2 2020 | $108,000 | +116.0% | 16,038 | +45.2% | 0.00% | – |
| Q1 2020 | $50,000 | -23.1% | 11,044 | +3.5% | 0.00% | – |
| Q4 2019 | $65,000 | -3.0% | 10,667 | +12.8% | 0.00% | – |
| Q3 2019 | $67,000 | +9.8% | 9,455 | +0.3% | 0.00% | – |
| Q2 2019 | $61,000 | -33.7% | 9,423 | -14.7% | 0.00% | – |
| Q1 2019 | $92,000 | +53.3% | 11,044 | +2.4% | 0.00% | – |
| Q4 2018 | $60,000 | -10.4% | 10,787 | +42.1% | 0.00% | – |
| Q3 2018 | $67,000 | +9.8% | 7,592 | +6.1% | 0.00% | – |
| Q2 2018 | $61,000 | +177.3% | 7,157 | +70.9% | 0.00% | – |
| Q1 2018 | $22,000 | +10.0% | 4,187 | +7.2% | 0.00% | – |
| Q4 2017 | $20,000 | -66.7% | 3,907 | -29.2% | 0.00% | – |
| Q3 2017 | $60,000 | +33.3% | 5,515 | +4.7% | 0.00% | – |
| Q2 2017 | $45,000 | -84.2% | 5,269 | -82.2% | 0.00% | -100.0% |
| Q1 2017 | $284,000 | -8.4% | 29,657 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $310,000 | +131.3% | 29,657 | +207.1% | 0.00% | +100.0% |
| Q3 2016 | $134,000 | +27.6% | 9,658 | +0.4% | 0.00% | 0.0% |
| Q2 2016 | $105,000 | -9.5% | 9,623 | +1.5% | 0.00% | 0.0% |
| Q1 2016 | $116,000 | -4.1% | 9,485 | +0.6% | 0.00% | 0.0% |
| Q4 2015 | $121,000 | +11.0% | 9,430 | +11.6% | 0.00% | 0.0% |
| Q3 2015 | $109,000 | -16.2% | 8,451 | +14.6% | 0.00% | 0.0% |
| Q2 2015 | $130,000 | – | 7,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 300 | $2,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |